J E Rachel Nivedita and Anu Vrat Sharma
Bharat Institute of Technology, India
Scientific Tracks Abstracts: J Nanomed Nanotechnol
Clinical trials are the backbone of Drug discovery and the study outcomes can change the fate of Drug under trial. It is therefore mandatory to ensure that the right medicine is reaching patients. The present study involved the use of quantum dot as a novel approach for a secured supply of the desired m edicine during clinical trials. The outcomes will be engaged at the minimal condition.
J E Rachel Nivedita is currently working in Bharat Institute of Technology, Mangalpaly, Hyderabad, Telangana, India. She has done various innovative technologies and participated in many conferences. Her research interests are nanomedicine, drug delivery, clinical trials, toxicology and pharmacology.